Emmanuelle Guitton - Publications
Affiliations: | Toulouse 3 |
Year | Citation | Score | |||
---|---|---|---|---|---|
2016 | Bagheri H, Lacroix I, Guitton E, Damase-Michel C, Montastruc JL. Cyberpharmacovigilance: What is the usefulness of the social networks in pharmacovigilance? ThéRapie. 71: 235-9. PMID 27080844 DOI: 10.1016/J.Therap.2015.09.002 | 0.43 | |||
2013 | Fuzier R, Serres I, Guitton E, Lapeyre-Mestre M, Montastruc JL. Adverse drug reactions to gabapentin and pregabalin: a review of the French pharmacovigilance database. Drug Safety. 36: 55-62. PMID 23315296 DOI: 10.1007/S40264-012-0006-6 | 0.551 | |||
2006 | Bandrant M, Bagheri H, Cuzin L, Sommet A, Bassoua V, Guitton E, Bonnet E, Garipuy D, Lucas F, Aquilina C, Montastruc JL, Massip P. [Not Available]. Therapie. 61: 171-6. PMID 27393319 DOI: 10.2515/Therapie:2006024 | 0.576 | |||
2006 | Baudrant M, Bagheri H, Cuzin L, Sommet A, Bassoua V, Guitton E, Bonnet E, Garipuy D, Lucas F, Aquilina C, Montastruc JL, Massip P. [Analysis of antiretroviral drugs-induced adverse effects]. Thã©Rapie. 61: 171-6. PMID 16886711 | 0.613 | |||
2006 | Guitton E, Montastruc JL, Lapeyre-Mestre M. Influence of HCV or HBV coinfection on adverse drug reactions to antiretroviral drugs in HIV patients. European Journal of Clinical Pharmacology. 62: 243-9. PMID 16416303 DOI: 10.1007/S00228-005-0080-0 | 0.498 | |||
Show low-probability matches. |